AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Sopharma AD

Earnings Release Mar 5, 2020

2543_rns_2020-03-05_254e1d94-cbf7-40d5-93bd-f758054a039a.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Current report №6/ 2020 Dated March 5, 2020

NOTIFICATION

Sopharma AD (the "Company") notifies that for February 2020 the Company recorded a decrease in sales of 22% compared to the same month of 2019, incl. 1% decrease in sales for the domestic market and 30% decrease in export sales.

In the first two months of 2020 the revenues from sales of production decreased by 15% compared to the same period of 2019, incl. 2% decrease in domestic sales and 20% increase in export sales.

Signatures of individuals authorized to represent the Company:

Ognian Donev

Talk to a Data Expert

Have a question? We'll get back to you promptly.